Fosravuconazole is under clinical development by Eisai and currently in Phase III for Fungal Infections. According to GlobalData, Phase III drugs for Fungal Infections have a 53% phase transition ...
The incidence of fungal endophthalmitis primarily ... severity of the infection and response to treatment. It is important to emphasize that a team approach involving both the ophthalmologist ...
Drug-resistant infections not only increase the length of hospital stay, they also drive up the treatment costs by more than 40 per cent, shows a recently published study by researchers from the ...
A – This is a very painful condition. Pour in a little olive oil or water, which may kill the insect. Try to sleep. Consult an ENT surgeon in the morning if it happened at night. If there is bleeding, ...
Pulmonary aspergillosis presents with a variety of clinical forms including invasive pulmonary aspergillosis, chronic necrotising aspergillosis, aspergilloma, chronic cavitary pulmonary aspergillosis ...